Received Oct 13, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | FA7485 | — |
Sick; I have not been able to work since; This is a spontaneous report received from a Consumer or other non HCP. A 57-year-old female patient received BNT162b2 (BNT162B2), on 14Sep2021 as dose 1, single (Lot number: FA7485) at the age of 57 years for covid-19 immunisation. The patient's relevant medical history included: "depressed" (ongoing); "anxiety" (unspecified if ongoing). Concomitant medication(s) included: WELLBUTRIN; LEXAPRO; LORAZEPAM. The following information was reported: ILLNESS (hospitalization) with onset 2021, outcome "unknown", described as "Sick"; LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (non-serious), outcome "unknown", described as "I have not been able to work since".; Sender's Comments: Linked Report(s) : US-PFIZER INC-202500198212 same patient, different vaccine dose number/event;US-PFIZER INC-PV202300015030 same patient, different vaccine dose number/event;
Depression
Medical History/Concurrent Conditions: Anxiety
WELLBUTRIN; LEXAPRO; LORAZEPAM